{"url_path":"/sec/dhcnl/8-k/2026-06-01/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1075415/0001104659-26-068894-index.html","accession_number":"0001104659-26-068894","cik":"0001075415","ticker":"DHC","issuer_name":"DIVERSIFIED HEALTHCARE TRUST","edgar_url":"https://www.sec.gov/Archives/edgar/data/1075415/0001104659-26-068894-index.html","primary_entity_key":"0001075415","primary_entity_name":"DIVERSIFIED HEALTHCARE TRUST"},"word_count":331,"has_tables":true,"body_markdown":"false\n0001075415\n\n0001075415\n\n2026-06-01\n2026-06-01\n\n0001075415\n\nus-gaap:CommonStockMember\n\n2026-06-01\n2026-06-01\n\n0001075415\n\nDHC:SeniorNotesDue2042Member\n\n2026-06-01\n2026-06-01\n\n0001075415\n\nDHC:SeniorNotesDue2046Member\n\n2026-06-01\n2026-06-01\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED STATES\nSECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, DC 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT PURSUANT**\n\n**TO SECTION 13 OR 15(d) OF THE\nSECURITIES EXCHANGE ACT OF 1934 **\n\n \n\nDate of report (Date of earliest event reported):\nJune 1, 2026\n\n \n\n**Diversified Healthcare Trust**\n\n(Exact Name of Registrant as Specified in\nIts Charter)\n\n \n\n**Maryland**\n\n(State or Other Jurisdiction of Incorporation)\n\n \n\n**001-15319**\n \n**04-3445278**\n\n(Commission File Number)\n \n(IRS Employer Identification No.)\n\n \n\n**Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts\n02458-1634**\n\n(Address of Principal Executive Offices) (Zip Code)\n\n \n\n**617-796-8350**\n\n(Registrant’s Telephone Number, Including\nArea Code)\n\n \n\nCheck the appropriate box below if the\nForm 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n  \n\n¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n  \n\n¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n  \n\n¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\n**Title Of Each Class**\n \n**Trading Symbol(s)**\n \n**Name Of Each Exchange On Which Registered**\n\nCommon\nShares of Beneficial Interest\n \nDHC\n \nThe\nNasdaq Stock Market LLC\n\n5.625%\nSenior Notes due 2042\n \nDHCNI\n \nThe\nNasdaq Stock Market LLC\n\n6.25%\nSenior Notes due 2046\n \nDHCNL\n \nThe\nNasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant\nis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2\nof the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth company ¨\n\n \n\nIf an emerging growth company, indicate\nby check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial\naccounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨"}